insights_auto
Why is ALK-B down 2,37%?
Dive Deeperchevron_right
ALK-B:CPH
ALK-Abello A/S
DKKÂ 239,20
arrow_downward
-2,37%(-5,80) 1D
20 Nov., 17:00:00 GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKKÂ 243,80
High
DKKÂ 244,00
Low
DKKÂ 238,60
Mkt. cap
49,63Â mjd.
Avg. vol.
203,93Â k
Volume
185,88Â k
52-wk high
DKKÂ 271,40
52-wk low
DKKÂ 191,80
Shares outstanding
202,57Â m.
No. of employees
3Â k
Open
DKKÂ 243,80
High
DKKÂ 244,00
Low
DKKÂ 238,60
Mkt. cap
49,63Â mjd.
Avg. vol.
203,93Â k
Volume
185,88Â k
52-wk high
DKKÂ 271,40
52-wk low
DKKÂ 191,80
Shares outstanding
202,57Â m.
No. of employees
3Â k
News stories
From web sources and news partners
MedWatch
·
1 dag gelede
ALK study: Nasal spray easier to use than auto-injector in emergencies
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter J. Halling
Employees2,8Â k
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net